Figure Legends
Table 1: Baseline characteristics of studies included in our
meta-analysis
Figure 1: A – The forest plot for pooled weighted mean
difference (WMD) for change in QTc interval (maximum QTc – baseline
QTc) in COVID-19 patients treated with hydroxychloroquine (HCQ) vs.
hydroxychloroquine + Azithromycin (HCQ + AZ); B - The forest
plot for risk of QTc prolongation > 500 ms in COVID-19
patients treated with hydroxychloroquine (HCQ) vs. hydroxychloroquine +
Azithromycin (HCQ + AZ); C - The forest plot for risk of TdP in
COVID-19 patients treated with hydroxychloroquine (HCQ) vs.
hydroxychloroquine + Azithromycin (HCQ + AZ).
Table 1 Baseline characteristics of studies included in our
pooled analysis.